Li, X.-Q.; Thelingwani, R.S.; Bertilsson, L.; Diczfalusy, U.; Andersson, T.B.; Masimirembwa, C.
Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug–Drug Interaction in Healthy Volunteers. J. Pers. Med. 2021, 11, 457.
https://doi.org/10.3390/jpm11060457
AMA Style
Li X-Q, Thelingwani RS, Bertilsson L, Diczfalusy U, Andersson TB, Masimirembwa C.
Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug–Drug Interaction in Healthy Volunteers. Journal of Personalized Medicine. 2021; 11(6):457.
https://doi.org/10.3390/jpm11060457
Chicago/Turabian Style
Li, Xue-Qing, Roslyn Stella Thelingwani, Leif Bertilsson, Ulf Diczfalusy, Tommy B. Andersson, and Collen Masimirembwa.
2021. "Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug–Drug Interaction in Healthy Volunteers" Journal of Personalized Medicine 11, no. 6: 457.
https://doi.org/10.3390/jpm11060457
APA Style
Li, X.-Q., Thelingwani, R. S., Bertilsson, L., Diczfalusy, U., Andersson, T. B., & Masimirembwa, C.
(2021). Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug–Drug Interaction in Healthy Volunteers. Journal of Personalized Medicine, 11(6), 457.
https://doi.org/10.3390/jpm11060457
